PREVALENCE OF CUTANEOUS ADVERSE DRUG REACTIONS ACCORDING TO IRAQI PHARMACOVIGILANCE CENTER; A RETROSPECTIVE STUDY FOR 11 YEARS (2010-2021)



Account has been disabled due to a violation of Terms of Service.

Contact Moderators